Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bruce Dzyngel
Observed names:
B Dzyngel,
B. Dzyngel
Institution:
Vale (Canada)
Observed institutions:
University of Toronto,
Vale (Canada)
OpenAlex ID:
A5080534839
Sublingual apomorphine (APL‐130277) for the acute conversion of OFF to ON in Parkinson's disease
2016
·
Robert A. Hauser
, C. Warren Olanow
, et al.
·
Movement Disorders
·
84
PDF
The Effect of Structured Versus Conventional Inhaler Education in Medical Housestaff
1996
·
David Rebuck
, Bruce Dzyngel
, et al.
·
Journal of Asthma
·
39
Defining the Asthma Phenotype for the Purpose of Genetic Analysis
1997
·
S. Kesten
, B. Dzyngel
, et al.
·
Journal of Asthma
·
5
OP16 A randomised, multi-centre, double-blind, placebo-controlled study of a targeted release oral cyclosporine formulation in the treatment of mild-to-moderate ulcerative colitis: efficacy results
2019
·
S Bloom
, T Iqbal
, et al.
·
Journal of Crohn s and Colitis
·
3
Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: results from the Phase 3 study dose-titration phase (P1.017)
2017
·
Robert A. Hauser
, Stuart Isaacson
, et al.
·
Neurology
·
3
Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease (P2.335)
2016
·
Robert Hauser
, Bruce Dzyngel
, et al.
·
Neurology
·
3
Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease (P2.337)
2016
·
Stuart Isaacson
, Eric Pappert
, et al.
·
Neurology
·
3
Efficacy of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease
2015
·
Albert Agro
, Jordan Dubow
, et al.
·
Parkinsonism & Related Disorders
·
3
The Effects of Sublingual Apomorphine (APL-130277) by Disease Severity on the Acute Management of OFF Episodes in Parkinson’s Disease (P2.336)
2016
·
Holly Shill
, Eric Pappert
, et al.
·
Neurology
·
2
713 A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of a Targeted Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Influence of Immunosuppressants at Baseline
2019
·
Stuart Bloom
, Tariq Iqbal
, et al.
·
The American Journal of Gastroenterology
·
1
Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the OFF to ON state
2015
·
Jordan Dubow
, Bruce Dzyngel
, et al.
·
Parkinsonism & Related Disorders
·
1
The effects of sublingual apomorphine (APL-130277) by disease severity on the acute reversal of OFF episodes in Parkinson’s disease patients
2015
·
Jordan Dubow
, Bruce Dzyngel
, et al.
·
Parkinsonism & Related Disorders
·
1
Efficacy of sublingual apomorphine (APL-130277) for the treatment of off episodes in patients with Parkinson's disease
2015
·
Albert Agro
, Jordan Dubow
, et al.
·
Parkinsonism & Related Disorders
·
1
Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the off to on state
2015
·
Jordan Dubow
, Bruce Dzyngel
, et al.
·
Parkinsonism & Related Disorders
·
1
Disease severity does not predict effective ON-turning dose of apomorphine sublingual film (APL-130277) in patient with Parkinson’s disease (P1.023)
2017
·
Hubert Fernandez
, Stuart Isaacson
, et al.
·
Neurology
Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the OFF to full ON state with sublingual apomorphine (APL-130277)
2015
·
Jordan Dubow
, Bruce Dzyngel
, et al.
·
Parkinsonism & Related Disorders
Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the off to full on state with sublingual apomorphine (APL-130277)
2015
·
Jordan Dubow
, Bruce Dzyngel
, et al.
·
Parkinsonism & Related Disorders
Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease
2015
·
Albert Agro
, Jordan Dubow
, et al.
·
Parkinsonism & Related Disorders
Show more works
View as search
Works count:
18
Citation count:
150
H-index:
3
I10-index:
2
Year
Topic
Type